<table cellpadding="0.3pt" width="85%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="32%"></col>
<col width="31%"></col>
<col width="33%"></col>
<tbody>
<tr>
<td stylecode="Toprule " valign="top">
<paragraph>Concomitant Drug<content stylecode="bold"> </content>
</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>Effect onConcentration ofLamotrigine orConcomitant Drug</paragraph>
</td>
<td stylecode="Toprule " valign="top">
<paragraph>Clinical Comment<content stylecode="bold"> </content>
</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Estrogen-containing oralcontraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine   <br/>↓ levonorgestrel</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine concentrationsapproximately 50%. Decrease in levonorgestrel component by 19%.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Carbamazepineand carbamazepine epoxide<content stylecode="bold"> </content>
</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine  <br/>? carbamazepine epoxide</paragraph>
</td>
<td valign="top">
<paragraph>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.May increase carbamazepine epoxide levels.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Lopinavir/ritonavir</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine concentrationapproximately 50%.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Atazanavir/ritonavir</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine AUCapproximately 32%.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph> </paragraph>
</td>
<td valign="top">
<paragraph> </paragraph>
</td>
<td valign="top">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Phenobarbital/primidone</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Phenytoin</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine concentration approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td valign="top">
<paragraph>Rifampin</paragraph>
</td>
<td valign="top">
<paragraph>↓ lamotrigine</paragraph>
</td>
<td valign="top">
<paragraph>Decreased lamotrigine AUC approximately 40%.</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule " valign="top">
<paragraph>Valproate</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>↑ lamotrigine  <br/>? valproate<content stylecode="bold"> </content>
</paragraph>
</td>
<td stylecode="Botrule " valign="top">
<paragraph>Increased lamotrigine concentrations slightly more than 2-fold.There are conflicting study resultsregarding effect of lamotrigine onvalproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change invalproate concentrations in controlled clinical trials in patients with epilepsy.</paragraph>
</td>
</tr>
</tbody>
</table>